Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;35(6):1773-80.
doi: 10.1007/s10753-012-9496-8.

CD4(+)CD25 (+)CD127 (low/-) T cells: a more specific Treg population in human peripheral blood

Affiliations

CD4(+)CD25 (+)CD127 (low/-) T cells: a more specific Treg population in human peripheral blood

Ning Yu et al. Inflammation. 2012 Dec.

Abstract

The quantitative identification and enrichment of viable regulatory T cells (Treg) requires reliable surface markers that are selectively expressed on Treg. Foxp3 is the accepted marker of nTreg, but it cannot be used to isolate cells for functional studies. In this study, we compared four staining profiles of Treg, including CD4(+)CD25(high) T cells, CD4(+)CD39(+) T cells, CD4(+)CD73(+) T cells, and CD4(+)CD25(+)CD127(low/-) T cells. We found that CD4(+)CD25(+)CD127(low/-) T cells expressed the highest level of Foxp3 and had the strongest correlation with CD4(+)CD25(+)Foxp3(+) T cells, the accepted identifying characteristics for "real" nTreg cells. Moreover, functional data showed that CD4(+)CD25(+)CD127(low/-) T cells could effectively suppress the proliferation of CD4(+)CD25(-) T cells, suggesting that compared with the other three populations, CD4(+)CD25(+)CD127(low/-) T cells best fit the definition of naturally occurring regulatory T cells in human peripheral blood. Finally, we showed that CD4(+)CD25(+)CD127(low/-) can be used to quantitate Treg cells in individuals with systemic lupus erythematosus supporting the use of CD4(+)CD25(+)CD127(low/-) to identify human Treg cells.

PubMed Disclaimer

References

    1. Int Immunol. 1998 Dec;10(12):1969-80 - PubMed
    1. Science. 2003 Feb 14;299(5609):1057-61 - PubMed
    1. Eur J Immunol. 2010 Jan;40(1):134-41 - PubMed
    1. J Invest Dermatol. 2010 Feb;130(2):492-9 - PubMed
    1. Eur J Immunol. 2004 Nov;34(11):2996-3005 - PubMed

Publication types

LinkOut - more resources